Literature DB >> 16699312

IgD positive L&H cells identify a unique subset of nodular lymphocyte predominant Hodgkin lymphoma.

Sonam Prakash1, Thomas Fountaine, Mark Raffeld, Elaine S Jaffe, Stefania Pittaluga.   

Abstract

Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) is a rare B-cell lymphoma considered to be of germinal center (GC) derivation. Studies on immunoglobulin expression have been few, and post-switch immunoglobulin (IgG) has been identified in the majority of cases examined thus far. We reviewed 180 cases of NLPHL and observed the unexpected expression of IgD in 27% of cases. IgD is usually coexpressed with IgM in naive B cells but can also be seen as IgD-only in centroblasts (CD38-positive) or memory B cells (CD27-positive). We asked whether IgD-positive NLPHL differed from cases of NLPHL negative for IgD. Clinically, the IgD-positive cases presented at a younger median age (21 vs. 44 years) and had a striking male predominance (male-to-female ratio, 23:1 vs. 1.5:1). Cervical lymph nodes were more frequently involved (56% vs. 18.2%). L&H cells were localized in a predominantly extrafollicular distribution in the majority of IgD-positive cases (69%). The IgD-positive cases did not coexpress IgM or CD27 (a marker associated with memory B cells), and nearly all (93%) were weakly positive for CD38, supporting a GC derivation. The expression of Bcl-6, BOB.1, Oct2, and SWAP-70 was similar in the two groups. However, PU.1 expression was seen in 60% of the IgD-positive cases in contrast to 86% of the IgD-negative cases. The absence of PU.1 staining correlated with more L&H cells in an extrafollicular distribution, weakening the use of this marker in the differential diagnosis with T-cell rich/histiocyte rich B-cell lymphomas. To study IgD expression in "de-novo" T-cell rich/histiocyte rich B-cell lymphomas, we analyzed 20 cases and all but one were negative. In conclusion, cases of IgD-positive NLPHL do not differ from IgD-negative cases regarding cellular derivation and most other immunophenotypic characteristics. However, IgD-positive NLPHL exhibits distinctive clinical features, and more often involves the interfollicular region in a background relatively rich in T cells. IgD positivity may represent an additional useful marker in the diagnosis of NLPHL.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16699312     DOI: 10.1097/01.pas.0000194741.87798.45

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  16 in total

Review 1.  Diagnosis of Hodgkin lymphoma in the modern era.

Authors:  Hao-Wei Wang; Jayalakshmi P Balakrishna; Stefania Pittaluga; Elaine S Jaffe
Journal:  Br J Haematol       Date:  2018-11-08       Impact factor: 6.998

2.  Variant histology, IgD and CD30 expression in low-risk pediatric nodular lymphocyte predominant Hodgkin lymphoma: A report from the Children's Oncology Group.

Authors:  Ramona Vesna Untanu; Jason Back; Burton Appel; Qinglin Pei; Lu Chen; Allen Buxton; David C Hodgson; Peter F Ehrlich; Louis S Constine; Cindy L Schwartz; Robert E Hutchison
Journal:  Pediatr Blood Cancer       Date:  2017-08-12       Impact factor: 3.167

3.  A high number of IgG4-positive plasma cells rules out nodular lymphocyte predominant Hodgkin lymphoma.

Authors:  Kati Kiil; Julia Bein; Bianca Schuhmacher; Lorenz Thurner; Markus Schneider; Martin-Leo Hansmann; Sylvia Hartmann
Journal:  Virchows Arch       Date:  2018-09-26       Impact factor: 4.064

Review 4.  Is Hodgkin lymphoma just another B-cell lymphoma?

Authors:  Harald Stein; Roshanak Bob
Journal:  Curr Hematol Malig Rep       Date:  2009-07       Impact factor: 3.952

Review 5.  Hodgkin Lymphoma: Biology and Differential Diagnostic Problem.

Authors:  Taishi Takahara; Akira Satou; Toyonori Tsuzuki; Shigeo Nakamura
Journal:  Diagnostics (Basel)       Date:  2022-06-20

Review 6.  Evolution in the definition and diagnosis of the Hodgkin lymphomas and related entities.

Authors:  Thomas A Tousseyn; Rebecca L King; Falko Fend; Andrew L Feldman; Pierre Brousset; Elaine S Jaffe
Journal:  Virchows Arch       Date:  2022-10-24       Impact factor: 4.535

7.  EBV may be expressed in the LP cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in both children and adults.

Authors:  Alison R Huppmann; Alina Nicolae; Graham W Slack; Stefania Pittaluga; Theresa Davies-Hill; Judith A Ferry; Nancy Lee Harris; Elaine S Jaffe; Robert P Hasserjian
Journal:  Am J Surg Pathol       Date:  2014-03       Impact factor: 6.394

8.  Gray zones around diffuse large B cell lymphoma. Conclusions based on the workshop of the XIV meeting of the European Association for Hematopathology and the Society of Hematopathology in Bordeaux, France.

Authors:  Leticia Quintanilla-Martinez; Daphne de Jong; Antoine de Mascarel; Eric D Hsi; Philip Kluin; Yaso Natkunam; Marie Parrens; Stefano Pileri; German Ott
Journal:  J Hematop       Date:  2009-12-22       Impact factor: 0.196

9.  Nodular lymphocyte-predominant hodgkin lymphoma or T-cell/histiocyte rich large B-cell lymphoma: the problem in "grey zone" lymphomas.

Authors:  Frank X Zhao
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

10.  Pathobiology of hodgkin lymphoma.

Authors:  Pier Paolo Piccaluga; Claudio Agostinelli; Anna Gazzola; Claudio Tripodo; Francesco Bacci; Elena Sabattini; Maria Teresa Sista; Claudia Mannu; Maria Rosaria Sapienza; Maura Rossi; Maria Antonella Laginestra; Carlo A Sagramoso-Sacchetti; Simona Righi; Stefano A Pileri
Journal:  Adv Hematol       Date:  2010-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.